We are live on ! Find out more
USNA icon

Usana Health Sciences

142 hedge funds and large institutions have $567M invested in Usana Health Sciences in 2016 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 40 increasing their positions, 55 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

57% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 14

4% more funds holding

Funds holding: 136142 (+6)

3.71% less ownership

Funds ownership: 88.75%85.04% (-3.7%)

11% less capital invested

Capital invested by funds: $636M → $567M (-$68.4M)

27% less repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 55

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
142
Holders Change
+6
Holders Change %
+4.41%
% of All Funds
3.79%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
22
Increased
40
Reduced
55
Closed
14
Calls
Puts
Net Calls
Net Calls Change

USNA Hedge Fund Activity: Q2 2016 in Review

142 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q2 2016, worth a combined $567M — down 11% from $636M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new USNA positions and 14 closed out — a net gain of 8 holders — while 40 added to existing stakes and 55 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $6.96M. The largest seller was Vanguard Group, cutting an estimated $14.7M.

  • 142 institutional investors held Usana Health Sciences (USNA) as of Q2 2016, up from 136 in Q1 2016.
  • Funds reported $567M of Usana Health Sciences stock for Q2 2016, down 11% quarter-over-quarter.
  • 22 funds opened new Usana Health Sciences positions in Q2 2016 and 14 closed out, a net change of +8 holders.
  • The largest Usana Health Sciences buyer in Q2 2016 was Renaissance Technologies, an estimated $6.96M added.
  • The largest Usana Health Sciences seller in Q2 2016 was Vanguard Group, an estimated $14.7M sold.

Based on aggregated 13F filings for Q2 2016.